Serum apolipoprotein A-IV levels are associated with flow-mediated dilation in patients with type 2 diabetes mellitus
Abstract Background Endothelial dysfunction is common in diabetes. Apolipoprotein (apo) A-IV functions to antagonize inflammation and oxidative stress. The present study aimed to investigate the relationship between flow-mediated dilation (FMD) and serum apoA-IV level in type 2 diabetes mellitus (T2...
Main Authors: | Le-Ying Li, Shuai Chen, Yi-Xuan Wang, Ri Ji, Feng-Hua Ding, Xiao-Qun Wang, Qiu-Jing Chen, Lin Lu, Yang Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-022-02898-x |
Similar Items
-
Evaluation of Endothelial Functions of Psoriasis Patients by Flow Mediated Dilatation Method
by: Mustafa Oylumlu, et al.
Published: (2015-11-01) -
Assessment of endothelial dysfunction by flow mediated dilatation in patients with Coronary Artery Disease
by: Saba F. Salih, et al.
Published: (2016-01-01) -
An observational study of the endothelial dysfunction in type 2 diabetes mellitus and its association with risk factors
by: Kesar Vinodbhai Prajapati, et al.
Published: (2022-01-01) -
The effect of exercise on flow-mediated dilation in people with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
by: Bopeng Qiu, et al.
Published: (2024-03-01) -
Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study
by: Barbara Kollerits, et al.
Published: (2024-03-01)